Measles outbreak associated with a preschool setting among partially vaccinated children in the Tel Aviv District, Israel, October 2023.

Measles Measles outbreak Vaccine preventable diseases Viral diseases

Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
15 Apr 2024
Historique:
received: 07 01 2024
revised: 07 03 2024
accepted: 04 04 2024
medline: 17 4 2024
pubmed: 17 4 2024
entrez: 16 4 2024
Statut: aheadofprint

Résumé

In October 2023, the Tel Aviv District was notified of ten cases of measles. The outbreak initiated in a preschool with high vaccination coverage with one dose of MMR vaccine. Serological testing was available for eight patients (six children and two adults). Among the six children vaccinated with one dose of MMR vaccine, primary vaccine failure was demonstrated. Among the adults, secondary vaccine failure was confirmed. The outbreak was successfully contained due to a combination of factors, notably its occurrence within a population characterized by high vaccination coverage in Tel Aviv, during a period of restricted public interactions due to the prevailing state of war in the country. Despite challenging wartime conditions, effective prophylactic measures were promptly executed, encompassing a 2-dose MMR vaccination schedule for close contacts and the broader community of children in the TA district, successfully curbing the outbreak and preventing widespread infections.

Identifiants

pubmed: 38627149
pii: S0264-410X(24)00427-4
doi: 10.1016/j.vaccine.2024.04.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rivka Sheffer (R)

Tel Aviv District Health Office, Ministry of Health, Israel.

Efrat Bucris (E)

Central Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan 5266202, Israel.

Ziva Amitai (Z)

Tel Aviv District Health Office, Ministry of Health, Israel.

Victoria Indenbaum (V)

Central Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan 5266202, Israel.

Yaniv Lustig (Y)

Central Virology Laboratory, Public Health Services, Ministry of Health, Chaim Sheba Medical Center, Ramat Gan 5266202, Israel; School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Michal Savion (M)

Tel Aviv District Health Office, Ministry of Health, Israel.

Naama Nuss (N)

Tel Aviv District Health Office, Ministry of Health, Israel.

Shepherd Roee Singer (S)

Israel Ministry of Health, Jerusalem, Israel; Hadassah/Hebrew University Braun School of Public Health, Israel.

Sharon Alroy Preis (S)

Israel Ministry of Health, Jerusalem, Israel.

Sharon Almagor (S)

Tel Aviv District Health Office, Ministry of Health, Israel.

Eyal Leshem (E)

School of Medicine, Tel Aviv University, Tel Aviv, Israel; Division of Infectious Diseases, Chaim Sheba Medical Center, Ramat Gan 5266202, Israel.

Matanelle Salama (M)

Tel Aviv District Health Office, Ministry of Health, Israel. Electronic address: Matanelle.salama@gmail.com.

Classifications MeSH